Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent.
about
Molecular targets of isothiocyanates in cancer: recent advancesPharmacokinetics and pharmacodynamics of phenethyl isothiocyanate: implications in breast cancer prevention.Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.Naturally occurring phenethyl isothiocyanate-induced inhibition of gastric cancer cell growth by disruption of microtubules.MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells.Dietary Glucosinolates Sulforaphane, Phenethyl Isothiocyanate, Indole-3-Carbinol/3,3'-Diindolylmethane: Anti-Oxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics and In Vivo Cancer Chemopreventive Efficacy.Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.Inhibition of cancer antioxidant defense by natural compounds.New Mild and Simple Approach to Isothiocyanates: A Class of Potent Anticancer Agents.A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target.PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.Cytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B
P2860
Q28307527-9CBDE39B-8171-4EFE-BDE6-B61DD7E8517BQ33803972-3AA140F3-AE3B-404D-8330-C89F08902A09Q34348403-5BA2C6CD-8097-4818-BBA4-7964664DBFBFQ34663720-AC1EFD92-7828-4741-B5EA-E426B37295F8Q35349299-F8FAD99A-85CD-4E65-B757-AE45182E843FQ35529542-B87F858E-668E-41FE-86F9-DD6ACD6B68F8Q36050048-E35B34B5-4C41-4539-AB9B-F9E2E0D0AE3AQ36131792-DE683E10-947A-408F-A508-2AE6725FBF8EQ37348076-C207A86A-AB0A-43A6-BC47-A17DF33B0D95Q37599071-2F2902AA-1C6A-4C63-A03D-C8C4CA8CEAF5Q37687440-8CF79318-0B68-4C7B-B329-BDF80748CA4AQ37716657-EC4B3BC0-9774-454C-B5EA-54FDD975B4F5Q38701124-B8FD0C9B-CFB2-42BE-983D-CD1C17C47041Q38711336-F9F3B02C-3EAA-4443-B0BC-67E5746852E2Q38826788-3E722CA1-9F62-4D4F-AB20-D427D6EE1A59Q39108537-E40A13C4-C037-4F6E-890B-296867ED94C3Q58773062-07DF17E3-C702-44C3-AB54-69D862DC324E
P2860
Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Differential induction of apop ...... a glutathione depleting agent.
@ast
Differential induction of apop ...... a glutathione depleting agent.
@en
type
label
Differential induction of apop ...... a glutathione depleting agent.
@ast
Differential induction of apop ...... a glutathione depleting agent.
@en
prefLabel
Differential induction of apop ...... a glutathione depleting agent.
@ast
Differential induction of apop ...... a glutathione depleting agent.
@en
P2860
P1476
Differential induction of apop ...... a glutathione depleting agent
@en
P2093
Alison Donlevy
Breeze E Cavell
P2860
P2888
P304
P356
10.1007/S12192-012-0329-3
P577
2012-02-17T00:00:00Z